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Abstract:
Introduction: There have many reported differences in the gut microbiota composition in
children with autism spectrum disorder (ASD) compared to typically developed (TD) healthy
cohorts (HC). This study aims to review existing literature and current studies regarding the role
of the gut microbiota in the development of ASD. Additionally, this study aims to determine if
there is a correlation between gut microbiome dysbiosis and an increased severity in ASD
symptoms. Methods: An extensive literature search was conducted following the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) system. A total of 7
databases including PubMed and MEDLINE were used and a total of 591 records were screened
and assessed for eligibility. Results: A total of 10 papers were included. The studies ranged from
6-143 participants with ASD who were between the ages of 2 to 13 years old and were from
various geographical locations throughout the world including China, the United States, and
Slovakia. Also included in this study is one study that includes an animal model of 7-week-old
BTBR and B6 mouse models. All the studies included collected fecal samples. Studies reported
to be significantly higher in abundance in autistic children included Bacteroides spp., Firmicutes,
and Prevotella spp. A significant decrease in the abundance of Streptococcus and Lactobacillus
was also observed in the studies. The findings are inconsistent across studies as research is
limited on the gut microbiome in children with ASD and the role of gut dysbiosis on the severity
of ASD and related behavioral symptoms. Conclusion: A clear connection between the diversity
of the gut microbiome and the severity of ASD symptoms in children has been demonstrated
through review of the research. It can be determined that a greater diversity of gut microbiota is
associated with improved behavioral and gastrointestinal (GI) outcomes in children with ASD.
Gut microbiota is altered in children with ASD; however, further exploration is needed to
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determine whether this is a cause or effect of the condition. Additionally, further trials are
needed to determine the effectiveness of pre- or probiotics as well as alterations to the diet in
reducing autistic behaviors and improving GI symptoms.
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Objectives:
Those with autism spectrum disorder, commonly referred to as ASD, often experience a
myriad of health issues in relation to ASD; however, the most common is gastrointestinal issues.
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Commonly seen in children with ASD, gastrointestinal issues like irritable bowel syndrome
(IBS), irritable bowel disease (IBD), and Crohn’s disease often accompany ASD. Since
gastrointestinal disorders are so common in those with ASD, it brings up an interesting thought,
that perhaps those with ASD have unique gut microbiomes due to the presence of autism
spectrum disorder. This systematic review aims to analyze current studies and research
surrounding the gut microbiome of children with autism spectrum disorder to determine interpret
current research findings of the interaction between ASD and gut microbiota composition.
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Introduction:
The concept of a connection between the overall health of gastrointestinal health or gut
health as related to brain function is a new area of study, despite the idea of a potential gut-brain
connection dating back to the 1700s (Alhadeff, 2021). The United States, among other countries
throughout the world, is facing a mental health crisis with cases of various mental and
neurological illnesses on the rise every minute (Dawson et al., 2016). As microbiologists,
neurologists, and even scientists of nutrition have conducted further research into the gut-brain
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connection, they have found that seemingly separate organ systems interact very closely with one
another and can even affect one another (Alhadeff, 2021). In the past decade, various areas of
research on the gut-brain connection have discovered that the influence of gut microbiota on

Commented [4]: ...influence off gut microbiota on...

mental and physical wellbeing is exponential. Research of this newfound connection has
exploded in the science field as more and more scientists are jumping on board to prove just how
vital this gut-brain connection is to our entire population’s well-being.
Autism spectrum disorder (ASD) is a severe neurodevelopmental disorder that is
primarily defined and categorized by a range of abnormal behavioral symptoms; symptoms such
as restricted interests, impairment in social interactions, and stereotyped behavior (Dan et al.,
2020). ASD diagnoses have doubled in a ten-year period, 2000-2010, from 6.7 to 14.7 per 1000
children (Berding et al., 2016). In 2010, nearly one in sixty-eight children were diagnosed with
some form of ASD that ranges in severity. Until recently no one thought to examine the
correlation between gut microbiomes and the severity of ASD symptoms, but doing so unlocks a
whole new world into possible treatment of ASD symptoms.
Autism spectrum disorder refers to a variety of complex neurodevelopmental disorders
that first occur during early stage of life (Zhang et al., 2018). ASD encompasses a variety of
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conditions including autistic disorder, Asperger syndrome, and pervasive developmental disorder
(Berding et al., 2016). ASD is typically defined by a presence of restrictive behaviors or
repetitive behaviors that are usually fixed behaviors, as well as the presence of deficits in social
and communication skills (Berding et al., 2016). ASD encompasses a wide variety of symptoms,
which can have a broad range of severity and can be unique between individual cases of the
disorder (Berding et al., 2016). In the past ten years there has been a steady incline in the number
of diagnoses of ASD that occur each year, although, the exact cause of the development of ASD
is unknown and is very difficult to study (Berding et al., 2016). Researchers have dwelled on the
exact cause of ASD and have been unsuccessful in pinpointing a cause, but it is likely that
environmental and genetic factors play a role in the development of this disorder. ASD is a
myriad of a variety of symptoms that can range in severity from patient to patient. Many patients,
especially pediatric patients, can experience non-neurological symptoms of ASD such as
gastrointestinal (GI) disorders, picky eating behaviors, unusual sleep patterns, and very rigidcompulsive behaviors (Zhang et al., 2018). Recently, it has been hypothesized that the gut
microbiome of children may play a significant role in ASD development and the severity of
symptoms (Berding et al., 2016). ASD is a highly complex neurodevelopmental disorder that is
very difficult to diagnosis and treat due to the variation among patients. For years, there has been
research conducted to determine new treatments for ASD; however, until recent, there was very
limited to no research exploring the effects that the gut have on the symptoms of ASD. Due to
the increasing prevalence of the disorder, nearly 1 out of every 68 children in the United States
being diagnosed with ASD, it is critical now more than ever to determine exactly what is
contributing to the development of this disease (Dan et al., 2020). A combination of factors
contributes to the development and severity of the disorder including environmental and genetic
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factors and gut dysbiosis that contributes to GI issues, increased behavioral issues, and a
dysregulation of associated metabolism activities that can affect the metabolic network of vital
neurotransmitters (Dan et al., 2020). It is very important to note that through the findings of this
review it can be determined that there is not a sole contributing factor to the development and
severity of ASD as shown in the current research, and rather there are many factors that
contribute to the development and severity of the disorder. A decreased gut microbiota diversity
is correlated to alterations in behavior and GI abnormalities (Coretti et al., 2018). This leads us to
this question: is a decreased gut microbiome diversity the cause of ASD and to blame for GI and
behavioral issues or does ASD cause a decreased gut microbiome diversity leading to the
alterations in behavior and GI abnormalities that ASD is defined by?
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Methods:
The PRISMA method was used to conduct and guide this systematic review to provide a
clear means of reporting information (Page et al., 2021). Inclusion criteria to be considered for
this systematic review were as follows: studies that included sample size cohorts that included
patients with ASD as well as neurotypical patients of the same age group; all patients were under
the age of fourteen years old; peer-reviewed scholarly studies and journal articles; studies and
research that were conducted within the last ten years. Studies that were eliminated for not
having a valid sample size either did not contain autism spectrum disorder patients compared to a
neurotypical cohort, or the sample size was less than five patients total. To conduct research, the
Johnson & Wales University Library Academic Complete database search was used as well as
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PubMed database search. There were no filters or limiters applied to searches to gather the
maximum possible results. These databases were last consulted October 22, 2021. Seven
databases were used to collect results (MEDLINE, PubMed, Johnson & Wales Univeristy
Complete Academic Database, Food Science Source, E-Journals, and Education Research
Complete) and the following search terms were used to find results; gut microbiome; gut
microbiota; pediatrics; children; autism spectrum disorder. Other systematic, literature, or
narrative reviews were removed in addition to duplicates from each of the database searches. For
analyses, the data was grouped based on human subjects, animal subjects, and peer-reviewed
journal articles relevant to the topic. Studies and articles were screened and determined for
potential bias, and there were determined to be no known bias.
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Results:
The selection process for the included studies is shown in Figure 1. The initial search
conducted identified 591 records from seven databases including Medline, PubMed, and Johnson
& Wales University complete academic database search. These, 579 articles and studies were
excluded due to ineligibility. Articles and studies that were ineligible were other systematic
reviews, periodicals, studies or articles of irrelevant subject matter, meta-analyses, narrative and
literature reviews, addendums, additional duplicates (not previously removed before screening),
descriptive reviews, re-prints, invalid sample sizes (less than 5 subjects), non-English articles
and studies, and abstracts. In the end, a total of 10 articles that reported on the gut microbiota in
children with and without ASD were included in this systematic review. Table 1 demonstrates
the type of bacteria that was discovered in the 10 included studies as well as the sample size,
sample collected, age group of the patients, and any interventions tested or pre-experiment
preparations used.
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Figure 1:
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Databases (n = 7)

Records screened and assessed
for eligibility
(n =591)

Studies included in review
(n = 10)

Records removed before
screening:
Duplicate records removed
(n=169)
Records marked as
ineligible by automation tools
(n = 0)
Records removed for other
reasons (n = 0)

Papers excluded**
(n = 579)

Reports excluded:
Periodicals (n = 2)
Systematic reviews (n = 22)
Corrigendum (n = 1)
Irrelevant to main subject
(n=153)
Meta-Analysis (n= 4)
Narrative reviews (n= 11)
Literature reviews (n=15)
Addendums (n=2)
Other duplicates (n=350)
Invalid sample size (n= 8)
Descriptive reviews (n=5)
Reprint (n=1)
Non-English (n=3)
Abstracts (n=4)

12
Rynearson
Table 1:
Author,
Year

Age,
Years

Specimen
Type

Children w/
ASD

TD1/NT2

Observed Trends in
the Gut Microbiome
of Children w/ ASD

Interventions
/ PreExperiment
Measures

Coretti et.
al 2018

2-4

Fecal

11

14

↑ Firmicutes: Bacteroidetes
ratio, Faecalibacterium
prausnitzii, Proteobacteria,
and Oscillospira

No intervention
used

Dan et. al
2020

Ding et. al
2020

2-13

2-7

Fecal

Fecal

143 (52 w/
constipation,
5 w/ diarrhea

143

77

50

↓Actinobacteria,
Actinomycetaceae,
Coriobacteriaceae,
Bifidobacteriaceae,
Gemellaceae, and
Streptococcaceae
↓Sutterella, Prevotella, and
Bacteroides.
Additionally, dysregulation
of metabolic activities in
neurotransmitter network

↑ Lachnospiraceae, Clostridiales,
Erysipelotrichaceae, Dorea,
Collinsella, and Lachnoclostridium
↓Bacteroides, Facalibacterium,
Parasutterella, and Paraprevotella
Presence of unitendified
Erysipelotrichaceae,
Faecalibacterium, and
Lachnospiraceae correlated with
ASD severity

Grimaldi
et. al 2018

Inoue et. al
2019

4-11

4-9

Fecal

Fecal

30 (divided
into 2
groups,
exclusion
diet/ nonrestricted

0

13

0

↑Faecalibacterium
prausnitzii and Bacteroides
spp.
↓Bifidobacterium spp. and
Veillonellaceae family
↑Genra Blautia and
Acidaminococcus
↓Streptococcus,
Odoribacter, and
Eubacterium (belonging to
the family
Erysipelotrichaceae)

Newell et.
al 2016

7wks

Fecal

25 (BTBR
mice)

21 (B6
mice)

↑Bacteroidetes
(Bacteroides/Prevotella
spp.)
↓Firmicutes (Clostridium
coccoides, Clostridium
leptum, Clostridium clusters
XI and I and Roseburia

All participants
did not take
antibiotics, proand prebiotic
interventions, or
other medications
3 months prior to
the start of the
study to prevent
any influence on
gut microbiota
composition
All participants
did not take
antibiotics, proand prebiotic
interventions, or
other medications
1 month prior to
the start of the
study to prevent
any influence on
gut microbiota
composition.
Intervention with
B-GOS®
prebiotic (no
exclusion diet).
This was
compared to a
control group on
an exclusion diet
Intervention with
a partially
hydrolyzed guar
gum
supplementation
(a form of
probiotic). This
was compared to a
control group with
no type of
intervention
Intervention with
BTBR mice on a
ketogenic diet.
This was
compared to B6
mice on a regular
chow diet
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Sun et. al
2019

3-12

Tomova et.
al 2018

2-9ASD/
5-17 non
ASD
siblings/ 211 TD

Fecal

3-8

Fecal

Zhang et.
al 2018

Fecal

9

10

35

6

10TD/ 9
non-ASD
siblings

6

spp., and Lactobacillus spp)
↑Ruminococcaceae
↓Bacteroidetes,
Selenomonadales,
Prevotellaceae
↑Clostridia cluster 1,
Desulfovibrio
↓ Firmicutes: Bacteroidetes
ratio

↑ Firmicutes: Bacteroidetes
ratio, Sutterella,
Odoribacter, and
Butyricimonas
↓Veillonella, Streptococcus,
and butyrate/ lactate
producers

Zou et. al
2021

2-6

Fecal

29

31

↑Candida sake,
Saccharomycetaceae,
Saccharomyces
↓Candida parapsilosis,
Trichocomaceae,
Asperigillus

1
2

TD- Typically Developed
NT- Neurotypical

No intervention
used

Intervention with
“Children
Dophilus”
probiotic
supplementation
with 60%
Lactobacillus (3
strains), 25%
Bifidumbacteria (
2 strains) and 15%
Streptococcus ( 1
strain) for four
months
All participants
did not take
antibiotics, proand prebiotic
interventions, or
other medications
1 month prior to
the start of the
study to prevent
any influence on
gut microbiota
composition
All participants
were not a special
diet or
medications like
probiotics or
antibiotics prior to
the start of the
study
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Discussion:
Through review of the research, it was determined that dysbiosis of the gut microbiome
does in fact increase the severity of ASD symptoms like increased behavioral issues, as well as
altered GI issues. An increase in particular bacterium types demonstrated a connection to an
increased prevalence of behavioral issues associated with ASD, as well as an increase of
negative GI issues like constipation and diarrhea. It was found that an imbalance of the gut
microbiota structure is caused by a shift in the colonization of beneficial bacteria species in early
childhood. Most of the research included in this review has determined that there is a decreased
diversity of beneficial bacteria in the ASD groups as compared to a typically developed (TD)
healthy cohort. Dysbiosis of gut microbiota contributes to the overall severity of ASD; the
greater dysbiosis of bacteria, the more severe the level of ASD has shown to be (Ding et al.,
2020), (Sun et al., 2019), (Zhang et al., 2018). Numerous types of bacteria on the phylum and
family levels were analyzed in most of the studies; however, the most notable finding as
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demonstrated in Table 1 was the variation in the findings of an increase or decrease in the
Firmicutes: Bacteroidetes ratio. Zhang et al., (2018) and Coretti et al., (2018) observed an
increase in the Firmicutes: Bacteroidetes ratio, whereas Tomara et al., (2018), Sun et al., (2018),
Newell et al., (2016), Ding et al., (2020), and Dan et al., (2020) observed a decrease in the
Firmicutes: Bacteroidetes ratio. Those that determined that ratio to be increased additionally
observed that the increased ratio could be positively correlated with an increase in the severity of
symptoms in children with ASD (Zhang et al., 2018), (Coretti et al., 2018). Adversely those
researchers that did not observe an increase in the ratio did observe that an increase in diversity
of bacteria is correlated with less severe ASD symptoms. They observed different increases in
different varieties of bacteria (Tomara et al., 2018), (Sun et al., 2018), (Newell et al., 2016),

Commented [10]: No comma

15
Rynearson
(Ding et al., 2020), and (Dan et al., 2020). Other types of dysbiotic microbiota profiles were also
shown to increase ASD symptoms; however, the Firmicutes: Bacteroidetes ratio is particularly
interesting because it changes throughout the life cycle (Mariat et al., 2009).
The Firmicutes: Bacteroidetes ratio evolves throughout the life cycle in a TD healthy
cohort (Mariat et al., 2009). Mariat et al., (2009), observed that Firmicutes: Bacteroidetes ratio is
the highest in adults and there is no difference between infants and the elderly in the ratio.
Although the aforementioned study was not conducted on individuals with ASD, it maintains
validity as it was observed in this study that in TD healthy cohorts, the diversity of microbiota in
the gut microbiome increases with age; however, in those with ASD it does not (Dan et al.,
2020). A variety of gut microbiota was observed in the TD healthy cohort and significant
differences throughout the varying ages of the TD children were observed (Dan et al., 2020). In
the ASD group, diversity did not increase with age and decreased amounts of beneficial bacteria
were observed (Dan et al., 2020). This significant finding could demonstrate a change in bacteria
composition occurs in early childhood may influence the gut ability to increase beneficial
bacteria throughout life in children with ASD. In addition, this limitation may affect the severity
of ASD symptoms. The next step in this hypothesis is to determine whether this change is driven
by the presence of ASD or firstly by the gut microbiota dysbiosis.
While further research needs to be conducted to determine if the lack of diversity in the
gut microbiota is due to ASD or vice versa, it was determined that by increasing the diversity in
gut microbiota, children with ASD saw a relief in previously debilitating GI symptoms (Inoue et
al., 2018). One study explored the impact that partially hydrolyzed guar gum (PHGG)
supplementation in the form of a probiotic was effective at alleviating constipation and diarrhea
symptoms in children with ASD in this region of Japan (Inoue et al., 2018). Not only did PHGG
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supplementation improve related GI symptoms, but it also decreased the level of inflammatory
cytokines in the body. These further improved symptoms of leaky-gut syndrome and vastly
improved symptoms of behavioral irritability (Inoue et al., 2018). Inside of our stomach, we have
more than 4,000 square feet of intestinal lining, and when fully functioning, it forms a tight
barrier that controls everything that gets absorbed into the bloodstream (Campos, 2021). When
the gut is unhealthy, it may have large cracks and holes that can allow partially digested food,
bugs, and toxins to absorb into the issues beneath it (Campos, 2021). This can cause change in
the gut microbiota composition and can trigger inflammation (Campos, 2021). PHGG
supplementation decreased the load of endotoxins from the intestine, resulting in a decreased
production of the serum inflammatory cytokines involved in leaky-gut syndrome (Inoue et al.,
2018). PHGG supplementation affected behavioral symptoms by improving constipation in
children with ASD and potentially blocked neuroinflammation in the central nervous system
(Inoue et al., 2018). Other studies also found that probiotic and prebiotic supplementation
interventions, like the PHGG, increased the diversity of gut microbiota and decreased the
Firmicutes: Bacteroidetes ratio. However, further research is needed to determine if pre- and
probiotics are an effective way to treat and manage ASD symptoms (Tomova et al., 2015). To
date pre- and probiotic supplementations are the interventions shown to improve and manage
symptoms of ASD in children (Inoue et al., 2018). Additionally, diet modification to the
ketogenic diet (KD) has been shown to improve ASD related symptoms (Newell et al., 2016).
Although Newell et al., (2016) did not test on human groups of children with ASD; they
did use BTBR T+ Itpr3tf/J (BTBR) mice to test the implication of the diet. BTBR mice have
been proven an effective model for human ASD without the spontaneous seizure activity
(Newell et al., 2016). B6 mice were used at the control cohort or the TD healthy cohort and were
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fed a normal chow diet, whereas the BTBR mice were fed a KD chow. In BTBR mice it was
found that the Firmicutes: Bacteroidetes ratio decreased with implication of the diet and increase
obligate anaerobes and beneficial gut microbiota further down the GI tract (Newell et al., 2016).
The KD diet increased the gut microbiota diversity in the BTBR mouse model and improved the
overall ASD symptoms. Interestingly, KD diet alone altered the microbial phenotype, which may
be the connection between the KD and improved ASD symptoms (Newell et al., 2016. These
findings are rather critical as they could unlock the potential therapeutic power of the KD diet in
treating the symptoms of ASD. This research while highly promising has only been conducted
on an animal model and needs to be conducted in a human ASD population to prove further
validity.
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Future Directions and Recommendations:
Current research regarding the development of ASD and the gut microbiome of children
with ASD is limited. To further establish if there is a link between the development of ASD and
dysbiosis in the gut, there needs to be an increase in the number of reputable studies and clinical
trials conducted to further support the link between the two. Additionally, these clinical trials
need to be conducted with an increased sample size. The greatest sample size that was found in
this review was 143 ASD and TD children with the fewest being 9 and 6 respectively (Dan et al.,
2020), (Sun et al., 2019). Future researchers should also consider expanding the areas of research
across many geographical locations. The current research that has been conducted is limited to
parts of China and the United States. Therefore, research applied to greater geographical
locations could further analyze the distinctions between ASD and TD children. Future studies
should focus on further investigation of the potential connection between diversity of the gut
microbiota and severity of ASD symptoms. It is vital for future research to establish if dysbiosis
in the gut is caused by ASD or if ASD is influenced by dysbiosis in the gut. Current studies
utilizing animal models are limited due to ethical concerns regarding the treatment of animals for
the purpose of experimentation. Animal models can only provide a model for ASD symptoms
and are not completely accurate in the presentation of the disorder, which limits results.
Additionally, when using human models to study ASD and the gut microbiota, results can be
limited when they require patient participation like collecting fecal samples, which relies solely
on the accurate collection of the patient.
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Conclusion:
ASD is a highly complex neurodevelopmental disorder that varies greatly from case to
case. There is limited research on the development of the disorder and effective therapeutic
treatments are limited. ASD is difficult to treat because it affects behavioral, physical, and
mental processes. This systematic review highlights potential links between decreased diversity
in the gut microbiome and severity of ASD symptoms. It can be determined that a lack of
diversity in the gut microbiota is associated with increased severity of both behavioral and
gastrointestinal ASD symptoms. Overall, improved diversity of beneficial gut microbiota may
improve related symptoms of ASD, therefore, improving the overall quality of life. When the gut
microbiota diversity is improved through pro- or prebiotic supplementation or diet modification,
an increase in microbiota diversity is observed along with a decrease in the Firmicutes:
Bacteroidetes ratio. Furthermore, current research supports the connection between gut
microbiota diversity and ASD development. However, further research must be conducted to
determine the pathophysiology of this connection. While more research is needed to find an
effective treatment for ASD, there is a growing body of research to support the role of gut
microbiota in the severity of ASD.
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